Funding Received
$5.4 Million in 9 Rounds from 10 Investors
Most Recent Funding
$1.5 Million on October 30, 2013 / Undisclosed Round
PneumaCare develops products for diagnosis and monitoring of respiratory diseases using novel 3D imaging technology.

Company Details


PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a number of medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device.

PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development laboratories at its design and manufacturing partner, Plextek.

PneumaScanâ„¢ produces standard medical outputs for a broader portion of the population because it observes patients from a distance and does not impede the respiratory system as with current spirometer technology. Measuring from a distance means lower infection risk, less harm, reduced patient discomfort and minimal instrument running costs from having to replace or sterilise parts which have contacted the patient.

Past Team (1)


Funding Rounds (9) - $5.4M


Products (2)


Offices/Locations (3)

  • Clinical Demo Facility

    Great Ormond Street Hospital

    London, WC1N 1LE


  • Clinical Demo Facility

    Addenbrooke's Hospital

    Hills Road

    Cambridge, CB2 0QQ


  • Cambridge Office

    St. John’s Innovation Centre

    Cowley Road

    Cambridge, CB4 0WS